SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-006652
Filing Date
2021-04-07
Accepted
2021-04-07 16:22:48
Documents
172
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 20-F pharm-20201231.htm   iXBRL 20-F 4984752
2 EX-4.3 descriptionofsecurities43.htm EX-4.3 250391
3 EX-12.1 pharmingsox302ceo.htm EX-12.1 7896
4 EX-12.2 pharmingsox302cfo.htm EX-12.2 8186
5 EX-13.1 pharmingsox906ceo.htm EX-13.1 4272
6 EX-13.2 pharmingsox906cfo.htm EX-13.2 4323
12 pharm-20201231_g1.jpg GRAPHIC 44070
13 pharm-20201231_g2.jpg GRAPHIC 161740
14 pharm-20201231_g3.jpg GRAPHIC 32501
15 pharm-20201231_g4.jpg GRAPHIC 33957
  Complete submission text file 0001628280-21-006652.txt   22904397

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pharm-20201231.xsd EX-101.SCH 163676
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pharm-20201231_cal.xml EX-101.CAL 194061
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pharm-20201231_def.xml EX-101.DEF 721205
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pharm-20201231_lab.xml EX-101.LAB 1239835
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pharm-20201231_pre.xml EX-101.PRE 988804
16 EXTRACTED XBRL INSTANCE DOCUMENT pharm-20201231_htm.xml XML 4669161
Mailing Address DARWINWEG 24 LEIDEN P7 2333 CR
Business Address DARWINWEG 24 LEIDEN P7 2333 CR 31 (0)71 5247 400
Pharming Group N.V. (Filer) CIK: 0001828316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39822 | Film No.: 21812382
SIC: 2834 Pharmaceutical Preparations